Re-assessing the risks of drug-induced arrhythmias during drug discovery
Drug Discovery World
AUGUST 15, 2023
However, development pipelines across multiple therapeutic areas are still not meeting the anticipated clinical outcomes that are needed for bringing new and cost-effective drugs to patients. 2012) Nature Reviews Drug Discovery, 11: 191–200. Journal of Cardiovascular Pharmacology, 20: S96-105 Aktas et al. Scannell & Bosley.
130 
Let's personalize your content